Rimifon and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rimifon (isoniazid) and Furosemide (furosemide). Common drug interactions include hepatic failure among females and toxic epidermal necrolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Rimifon and Furosemide. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Rimifon?

Rimifon has active ingredients of isoniazid. eHealthMe is studying from 925 Rimifon users. Check the latest studies of Rimifon.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

On Jul, 09, 2026

16 people who take Rimifon and Furosemide together, and have interactions are studied.

Rimifon and Furosemide drug interactions.

What are the common drug interactions of Rimifon and Furosemide, by gender? *:

female:

Hepatic failure (liver failure)
Hepatocellular damage (liver damage)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Prothrombin level decreased
Renal failure acute (rapid kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)

male:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Blood creatinine increased
Asthenia (weakness)
Cell death
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Epistaxis (bleed from the nose)
Haematuria (presence of blood in urine)
Hepatitis (inflammation of the liver)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

What are the common drug interactions of Rimifon and Furosemide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gamma-glutamyltransferase increased
Hepatocellular injury (liver injury)
Pruritus (severe itching of the skin)
Skin exfoliation (removal of the oldest dead skin cells)
Toxic skin eruption (skin breakdown due to toxic substance)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Hepatitis (inflammation of the liver)
Pyrexia (fever)

50-59:

Thrombocytopenia (decrease of platelets in blood)

60+:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Renal failure acute (rapid kidney dysfunction)
Haematuria (presence of blood in urine)
Hepatic failure (liver failure)
Hepatocellular damage (liver damage)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Lung cancer stage unspecified (exc metastatic tumours to lung) (lung cancer spreads to other parts with unspecified stage)
Malaise (a feeling of general discomfort or uneasiness)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the existing conditions these people have? *

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 12.50%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 6.25%
Lung Disorder (lung disease): 1 person, 6.25%
Latent Tuberculosis (hidden tuberculosis): 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%
Diarrhea: 1 person, 6.25%
Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Rimifon and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously